MAIA Biotechnology, Inc. (MAIA)

MAIA Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.6	8.66	9.6	7.15	10.95	10.57
Cash & Short-Term Investments	27.6	8.66	9.6	7.15	10.95	10.57
Cash Growth	172.03%	-9.82%	34.27%	-34.70%	3.56%	1493.82%
Other Receivables	-	-	0.08	0.14	0.3	0.04
Receivables	-	-	0.08	0.14	0.3	0.04
Prepaid Expenses	0.64	1.04	0.47	0.27	0.55	0.05
Total Current Assets	28.24	9.7	10.15	7.56	11.81	10.67
Long-Term Deferred Charges	-	-	-	-	0.21	0.65
Other Long-Term Assets	0	0	0	0	0	0
Total Assets	28.24	9.7	10.16	7.57	12.02	11.33

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.84	2.04	1.51	1.64	1.17	0.96
Accrued Expenses	3.42	3.8	2.32	3.3	2.1	1.19
Total Current Liabilities	6.26	5.84	3.83	4.94	3.27	2.15
Other Long-Term Liabilities	1.31	1.49	2.69	2.15	0.25	-
Total Liabilities	7.57	7.33	6.52	7.09	3.51	2.15

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	144.65	112.05	90.9	64.47	52.73	37.62
Retained Earnings	-123.94	-109.63	-87.23	-63.98	-44.21	-28.44
Comprehensive Income & Other	-0.04	-0.05	-0.03	-0.02	-0.02	-
Total Common Equity	20.68	2.38	3.63	0.48	8.51	9.18
Shareholders' Equity	20.68	2.38	3.63	0.48	8.51	9.18
Total Liabilities & Equity	28.24	9.7	10.16	7.57	12.02	11.33

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash (Debt)	27.6	8.66	9.6	7.15	10.95	10.57
Net Cash Growth	172.03%	-9.82%	34.27%	-34.70%	3.56%	5195.01%
Net Cash Per Share	0.62	0.27	0.43	0.54	1.18	2.00
Filing Date Shares Outstanding	60.83	60.67	29.59	20	11	7.94
Total Common Shares Outstanding	60.82	38.62	26.16	16.99	10.96	7.58
Working Capital	21.98	3.87	6.32	2.63	8.54	8.53
Book Value Per Share	0.34	0.06	0.14	0.03	0.78	1.21
Tangible Book Value	20.68	2.38	3.63	0.48	8.51	9.18
Tangible Book Value Per Share	0.34	0.06	0.14	0.03	0.78	1.21

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error